Autophagy a Close Relative of AML Biology.

Area of Science:

• Cell Biology
• Cancer Research
• Hematology

Background:

• Autophagy, a cellular degradation process, plays a dual role in cancer, acting as both a tumor suppressor and promoter.
• Its specific role in acute myeloid leukemia (AML) is increasingly understood, particularly in leukemogenesis and therapeutic resistance.

Purpose of the Study:

• To review recent findings on the mechanistic roles of autophagy in AML.
• To elucidate how autophagy contributes to leukemic transformation and progression.
• To summarize the ambivalent role of autophagy in response to cancer therapies.

Main Methods:

• Literature review of recent studies on autophagy in AML.
• Analysis of mechanisms including mitophagy, lipophagy, and fatty acid oxidation.
• Examination of autophagy's role in hematopoietic stem cell transformation and AML progression.

Main Results:

• Autophagy supports AML cell proliferation in vitro and leukemic progression in vivo.
• Mitophagy is essential for leukemic stem cell function and survival.
• Autophagy sustains fatty acid oxidation via lipophagy, supporting chemo-resistant cell metabolism.

Conclusions:

• Autophagy is a key driver of AML initiation and progression.
• Autophagy's role in therapy response is context-dependent, potentially being cytoprotective or cytotoxic.
• Targeting autophagy may offer therapeutic strategies for AML, but requires careful consideration of its dual role.